Home › CeloNova Announces Accelerated IDE Trial Enrollment Completion For Its COBRA PzF Coronary Stent System
 

Keywords :   


CeloNova Announces Accelerated IDE Trial Enrollment Completion For Its COBRA PzF Coronary Stent System

2015-02-20 03:50:57| surfacefinishing News Articles

CeloNova BioSciences, Inc. announced completion of patient enrollment in the global, multi-center IDE trial for its COBRA PzF stent. Completed enrollment was ahead of schedule and supports submission for FDA approval of the novel COBRA PzF stent with its advanced, nano-thin coating of Polyzene-F polymer

Tags: system trial completion ide

Category:Materials

Latest from this category

All news
»
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Graphics
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
More »